Sale of ADAMAS Consulting Group
to Ergomed plc

Deal typeM&A & Transaction Services
IndustryLife Sciences

BDO has provided sell-side M&A, vendor Commercial Due Diligence, Tax advice, Financial and Tax Vendor Assist and Financial Modelling to ADAMAS Consulting Group Ltd in connection with the sale to Ergomed plc, an AIM listed group.

ADAMAS is a well-established, leading provider of mission-critical regulatory compliance and consulting services to the global pharmaceutical industry, with a broad client base and expansive global reach, including the US, Europe and APAC.

The acquisition enhances Ergomed’s global presence and broadens the service offering to clients, whilst addressing the pharmaceutical industry’s ever-growing need for best practice quality assurance due to the increasing complexity of drug development, pharmacovigilance and manufacturing processes and associated regulatory requirements.

"The Pharma M&A team at BDO led by Jamie Austin were recommended to us by two independent parties a couple of years ago.  From the start they came across as a knowledgeable and professional team that could be trusted to manage the most important transaction of our lives.  We have not been disappointed!

Over the last twelve months the team has given us the guidance we needed, as well as the support and empathy during some challenging times to achieve an excellent outcome.  We wouldn’t hesitate to recommend Jamie and the team to other business owners looking to have a successful exit."

Dr Patricia Fitzgerald, Executive Chairman, ADAMAS Consulting Group Ltd

"The BDO M&A team have been pivotal in leading our sale process, from the initial preparation work through to buyer selection, negotiation and due diligence support. Their deep understanding of our business and extensive knowledge of the pharma sector was fundamental to the success of our transaction. The whole team were brilliant to work with – always pro-active, incredibly hard working, patient and flexible and they delivered a top class service and ultimately great value for our shareholders. What stood out for me was their overall leadership throughout the process and they were an absolute pleasure to work with."

Simon Pritchard, CFO, ADAMAS Consulting Group Ltd

"This is a brilliant deal for both parties, powering Adamas Consulting’s exceptional team and platform whilst strengthening Erogmed’s service offering and geographical reach. Having completed 15 Life Sciences deals in 2021, BDO are delighted to continue supporting entrepreneurial businesses in the next step of their journeys." 

Jamie Austin, M&A Partner, BDO